Document is current
Any future updates will be listed below
-
Authors
Siavashani, Elham Salehi
Ashrafi, Mahmoud Reza
Ghabeli, Homa
Heidari, Morteza
Garshasbi, Masoud
-
Funding
Funding for this research was provided by:
DeNA laboratory, Pardis Gene Technology company
- License Information
-
More Information
Article History
Received: 24 July 2022
Accepted: 22 August 2023
First Online: 26 September 2023
Declarations
:
: The study protocol was approved by the ethics committee of the National Institute for Medical Research Development (NIMAD), Tehran, Iran (Ethics ID: IR.NIMAD.REC.1397.508). The written informed consent was received from both guardians in order to participate in this study.
: Both guardians provided a signed written consent to publish all personal and medical details included in this study.
: The authors declare that they have no competing interests.
